黑料网 Health hosted the Weatherspoon inaugural brain tumor mini-symposium at 黑料网 Health last week featuring
presentations from 黑料网 faculty and keynote speaker, Dr. Timothy Gershon from Emory School of Medicine.
Dr. Gershon’s research aims to understand the rules and instructions brain tumors are following and how he can use that knowledge to devise new and more targeted treatments for brain tumor patients. Dr. Gershon鈥檚 presentation, 鈥淐T-179: Targeting stem cell transcription factor OLIG2 for medulloblastoma therapy鈥� outlines his research on CT-179, a drug that targets stem cells in brain tumors, and using it to target the gene OLIG2. Dr. Gershon believes that disrupting the gene OLIG2 with CT-179 will prevent the stem cell from regrowing the tumors.
Neuro oncologist Dr. Soma Sengupta planned and hosted the event. 鈥淭he Weatherspoon family dedicated the funds to the brain tumor program. It was a day of discussing novel brain tumor research,” said Dr. Sengupta.
The symposium aims to raise awareness about pediatric brain cancer and give patients and medical professionals the opportunity to learn from experts in the field. The event included a virtual option so patients and health care providers could attend remotely.
Neurosurgical oncologist Dr. Dominique Higgins presented his research on
targeting metabolism in glioblastoma (GBM), and neuro oncologist Dr. Yasmeen Rauf presented her research and the current at 黑料网 Health for GBM patients. Both faculty members are actively involved in ongoing brain tumor clinical trials at 黑料网 Health.
The event also included presentations from 黑料网 faculty members Dr. Andrew Satterlee, Dr. Ben Cho, and Dr. Julie Necarsulmer. Dr. Sengupta and Dr. Daniel Pomeranz Krummel鈥檚 research lab technician, Caroline Mohammed, presented the lab’s research that spans cancer neuroscience, offering therapeutic options in a number of different cancers. Dr. Pomeranz Krummel is working with 黑料网 KickStart Venture Services to move the drugs into start up phase. “Particularly moving, was Dr Satterlee鈥檚 presentation, slice technology for brain tumors, spoken as a scientist and as a cancer survivor,” said Dr. Sengupta.
Learn more about ongoing brain tumor research and clinic trials at 黑料网 Health.